EVOLENT HEALTH INC - A
EVHNYSETrading Snapshot
- Day Range
- $4.21 β $4.40
- 52-Week Range
- $2.10 β $7.66
- Volume (shares)
- 1,302,462
- Avg Volume (shares)
- β
- Shares Outstanding
- 113.1M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $1.88B
- Last Q Revenue
- $653M
- P/E Ratio
- β
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-4.52
- Dividend Yield
- β
- Dilution (1yr)
- β0.7%
EVOLENT HEALTH INC - A
EVHAbout EVOLENT HEALTH INC - A
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Analyzing CareCloud (NASDAQ:CCLD) & Evolent Health (NYSE:EVH)
Evolent Health (NYSE: EVH - Get Free Report) and CareCloud (NASDAQ: CCLD - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength

Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026
WASHINGTON, Oct. 9, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter 2026

Evolent Health, Inc (NYSE:EVH) Receives Consensus Recommendation of βModerate Buyβ from Brokerages
Evolent Health, Inc (NYSE: EVH - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the sixteen ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst h

TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
TransPerfect expands its Evolent partnership to provide enterprise-wide telephonic interpretation and strengthen language access for health plan members.

Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming
Evolent Health, Inc. is awarded a contrarian Buy rating despite extreme indebtedness and recent net losses. EVH trades at a deeply distressed valuation (~0.2x forward sales) due to ~$967m long-term debt and persistent GA

Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH
Dimensional Fund Advisors LP reduced its stake in Evolent Health, Inc (NYSE: EVH) by 22.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned